Covidien plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

November 2024 | 50 pages | ID: C9C52591D86BEN
BAC Reports

Abstracts

Covidien plc Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecasts made by stock market experts. The report also enables direct comparison to be made between Covidien plc and its competitors. This provides our Clients with a clear understanding of Covidien plc position in the Healthcare Equipment and Supplies Industry.

• The report contains detailed information about Covidien plc that gives an unrivalled in-depth knowledge about internal business-environment of the company: data about the owners, senior executives, locations, subsidiaries, markets, products, and company history.
• Another part of the report is a SWOT-analysis carried out for Covidien plc. It involves specifying the objective of the company's business and identifies the different factors that are favorable and unfavorable to achieving that objective. SWOT-analysis helps to understand company’s strengths, weaknesses, opportunities, and possible threats against it.
• The Covidien plc financial analysis covers the income statement and ratio trend-charts with balance sheets and cash flows presented on an annual and quarterly basis. The report outlines the main financial ratios pertaining to profitability, margin analysis, asset turnover, credit ratios, and company’s long-term solvency. This sort of company's information will assist and strengthen your company’s decision-making processes.
• In the part that describes Covidien plc competitors and the industry in whole, the information about company's financial ratios is compared to those of its competitors and to the industry. The unique analysis of the market and company’s competitors along with detailed information about the internal and external factors affecting the relevant industry will help to manage your business environment. Your company’s business and sales activities will be boosted by gaining an insight into your competitors’ businesses.
• Also the report provides relevant news, an analysis of PR-activity, and stock price movements. The latter are correlated with pertinent news and press releases, and annual and quarterly forecasts are given by a variety of experts and market research firms. Such information creates your awareness about principal trends of Covidien plc business.

About Covidien plc

Covidien plc engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings in the United States.

Segments

The company operates its businesses through three segments, including Medical Devices, Pharmaceuticals, and Medical Supplies.

Medical Devices

The Medical Devices segment engages in the development, manufacture, and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry and monitoring products, airway and ventilation products, and products used in vascular therapies and other medical products.

Endomechanical Instruments—includes laparoscopic instruments and surgical staplers.

Soft Tissue Repair Products—includes sutures, mesh, biosurgery products, and hernia mechanical devices.

Energy Devices—includes vessel sealing, electrosurgical, and ablation products and related capital equipment.

Oximetry and Monitoring Products—includes sensors, monitors, and temperature management products.

Airway and Ventilation Products—includes airway, ventilator, breathing systems and inhalation therapy products.

Vascular Products—includes compression, dialysis, venous insufficiency, thrombectomy, neurovascular, and peripheral vascular products.

In June 2010, the company announced the global launch of its Tri-Staple technology platform for endoscopic stapling, including the Endo GIA reloads with Tri-Staple technology and the Endo GIA ultra universal stapler, which allow surgeons to use staples in various laparoscopic procedures. It announced the worldwide launch of the SILS hand instrument, including SILS stitch, an articulating suturing device for advanced laparoscopic surgery.

The company offers the V-Loc absorbable wound closure device, a device that enables surgeons to close dermal wounds without tying knots. In May 2010, the company expanded its family of V-Loc absorbable wound closure devices with the global launch of the V-Loc 90, which contains absorbing material. The company offers the AbsorbaTack absorbable mesh fixation device for hernia repair and the Parietex ProGrip, a self-gripping, biocompatible solution for inguinal hernias, in the United States and Europe. It offers the Permacol biological implant, a biological mesh for hernia and abdominal wall repair.

The company develops and markets a line of biosurgery solutions, including internal sealants, topical adhesives and anti-adhesion products, which have applications in various types of surgical procedures. It offers DuraSeal spine sealant in the United States, the product approved by the U.S. Food and Drug Administration (FDA) for intra-operative sealing of the dural membrane during spine procedures.

The company offers energy-based medical systems and accessories worldwide, including products, such as the ForceTriad tissue fusing and electrosurgery system, the LigaSure vessel sealing system, the Cool-tip radiofrequency ablation system, the Evident microwave ablation system, and LigaSure Advance, a multifunctional laparoscopic instrument for use with the ForceTriad. It provides the LigaSure Advance pistol grip instrument, the 44 centimeter laparoscopic LigaSure device with dual energy modalities, the LigaSure 5 millimeter device.

The company offers a line of products used to monitor, diagnose, and treat respiratory disease. It owns Aspect Medical Systems, Inc., a provider of brain monitoring technology. It owns Somanetics Corporation, a developer of cerebral and somatic oximetry and monitoring systems.

The company offers the Mallinckrodt SealGuard Evac endotracheal tube, which reduces the incidence of Ventilator-Associated Pneumonia (VAP). In addition, it offers Mallinckrodt TaperGuard Evac endotracheal tubes, designed to reduce the entry of foreign material into the respiratory tract. The company offers the Puritan Bennett 560 ventilator, a portable homecare ventilator in Europe.

The company offers Bacchus Vascular, a medical device company dedicated to the treatment of peripheral vascular disease. It owns VNUS Medical Technologies, Inc., a developer of medical devices for treatment of venous reflux disease. The company owns ev3 Inc., by whic

The above Company Fundamental Report is a half-ready report and contents are subject to change.
It means that we have all necessary data in our database to prepare the report but need 2-3 days to complete it. During this time we are also updating the report with respect to the current moment. So, you can get all the most recent data available for the same price. Please note that preparation of additional types of analyses requires extra time.

Contents

RESEARCH METHODOLOGY

DISCLAIMER

1. COVIDIEN PLC COMPANY PROFILE

1.1. Key facts
1.2. Financial Performance
1.3. Key Executives
1.4. Ownership and Major Holders
1.5. Company History

2. COVIDIEN PLC BUSINESS OVERVIEW

2.1. Business Description
2.2. Major Products and Services
2.3. Markets and Sales Activities
2.4. Locations, Subsidiaries, Operating Units

3. COVIDIEN PLC SWOT ANALYSIS

3.1. Overview
3.2. Strengths
3.3. Weaknesses
3.4. Opportunities
3.5. Threats

4. COVIDIEN PLC FINANCIAL ANALYSIS

4.1. Financial Statements
4.1.1. Income Statement
4.1.2. Balance Sheet
4.1.3. Cash Flow
4.2. Financial Ratios
4.2.1. Profitability
4.2.2. Margin Analysis
4.2.3. Asset Turnover
4.2.4. Credit Ratios
4.2.5. Long-Term Solvency
4.2.6. Growth Over Prior Year
4.2.7. Financial Ratios Charts
4.3. Stock Market Snapshot

5. COVIDIEN PLC COMPETITORS AND INDUSTRY ANALYSIS

5.1. Covidien plc Direct Competitors
5.2. Comparison of Covidien plc and Direct Competitors Financial Ratios
5.3. Comparison of Covidien plc and Direct Competitors Stock Charts
5.4. Covidien plc Industry Analysis
5.4.1. Healthcare Equipment and Supplies Industry Snapshot
  5.4.2. Covidien plc Industry Position Analysis

6. COVIDIEN PLC NEWS & EVENTS

6.1. News & PR Activity Analysis
6.2. IR Corporate News
6.3. Marketing News
6.4. Corporate Events

7. COVIDIEN PLC EXPERTS REVIEW¹

7.1. Experts Consensus
7.2. Experts Revisions

8. COVIDIEN PLC ENHANCED SWOT ANALYSIS²

9. IRELAND PESTEL ANALYSIS²

9.1. Political Factors
9.2. Economic Factors
9.3. Social Factors
9.4. Technological Factors
9.5. Environmental Factors
9.6. Legal Factors

10. COVIDIEN PLC IFE, EFE, IE MATRICES²

10.1. Internal Factor Evaluation Matrix
10.2. External Factor Evaluation Matrix
10.3. Internal External Matrix

11. COVIDIEN PLC PORTER FIVE FORCES ANALYSIS²

12. COVIDIEN PLC VRIO ANALYSIS²

APPENDIX: RATIO DEFINITIONS

LIST OF FIGURES

Covidien plc Annual Revenues in Comparison with Cost of Goods Sold and Gross Profit
Profit Margin Chart
Operating Margin Chart
Return on Equity (ROE) Chart
Return on Assets (ROA) Chart
Debt to Equity Chart
Current Ratio Chart
Covidien plc 1-year Stock Charts
Covidien plc 5-year Stock Charts
Covidien plc vs. Main Indexes 1-year Stock Chart
Covidien plc vs. Direct Competitors 1-year Stock Charts
Covidien plc Article Density Chart

1 – Data availability depends on company’s security policy.
2 – These sections are available only when you purchase a report with appropriate additional types of analyses.
The complete financial data is available for publicly traded companies.

List Of Tables

LIST OF TABLES

Covidien plc Key Facts
Profitability
Management Effectiveness
Income Statement Key Figures
Balance Sheet Key Figures
Cash Flow Statement Key Figures
Financial Performance Abbreviation Guide
Covidien plc Key Executives
Covidien plc Major Shareholders
Covidien plc History
Covidien plc Products
Revenues by Segment
Revenues by Region
Covidien plc Offices and Representations
Covidien plc SWOT Analysis
Yearly Income Statement Including Trends
Income Statement Latest 4 Quarters Including Trends
Yearly Balance Sheet Including Trends
Balance Sheet Latest 4 Quarters Including Trends
Yearly Cash Flow Including Trends
Cash Flow Latest 4 Quarters Including Trends
Covidien plc Profitability Ratios
Margin Analysis Ratios
Asset Turnover Ratios
Credit Ratios
Long-Term Solvency Ratios
Financial Ratios Growth Over Prior Year
Covidien plc Capital Market Snapshot
Covidien plc Direct Competitors Key Facts
Direct Competitors Profitability Ratios
Direct Competitors Margin Analysis Ratios
Direct Competitors Asset Turnover Ratios
Direct Competitors Credit Ratios
Direct Competitors Long-Term Solvency Ratios
Healthcare Equipment and Supplies Industry Statistics
Covidien plc Industry Position
Company vs. Industry Income Statement Analysis
Company vs. Industry Balance Sheet Analysis
Company vs. Industry Cash Flow Analysis
Company vs. Industry Ratios Comparison
Covidien plc Consensus Recommendations¹
Analyst Recommendation Summary¹
Price Target Summary¹
Experts Recommendation Trends¹
Revenue Estimates Analysis¹
Earnings Estimates Analysis¹
Historical Surprises¹
Revenue Estimates Trend¹
Earnings Estimates Trend¹
Revenue Revisions¹

ANALYSIS FEATURES

SWOT Analysis

SWOT, which stands for Strengths, Weaknesses, Opportunities and Threats, is an analytical framework that identifies the internal and external factors that are favorable and unfavorable for a company.

Enhanced SWOT Analysis

Enhanced SWOT is a 3×3 grid that arranges strengths, weaknesses, opportunities and threats into one scheme:

• How to use the strengths to take advantage of the opportunities?
• How to use the strengths to reduce likelihood and impact of the threats?
• How to overcome the weaknesses that obstruct taking advantage of the opportunities?
• How to overcome the weaknesses that can make the threats a reality?

Upon answering these questions a company can develop a project plan to improve its business performance.

PESTEL Analysis

PESTEL (also termed as PESTLE) is an ideal tool to strategically analyze what influence different outside factors – political, economic, sociocultural, technological, environmental and legal – exert on a business to later chart its long term targets.

Being part of the external analysis when carrying out a strategic assessment or performing a market study, PESTEL gives an overview of diverse macro-environmental factors that any company should thoughtfully consider. By perceiving these outside environments, businesses can maximally benefit from the opportunities while minimizing the threats to the organization.

Key Factors Examined by PESTEL Analysis:

• Political – What opportunities and pressures are brought by political bodies and what is the degree of public regulations’ impact on the business?
• Economic – What economic policies, trends and structures are expected to affect the organization, what is this influence’s degree?
• Sociological – What cultural and societal aspects will work upon the demand for the business’s products and operations?
• Technological – What impact do the technological aspects, innovations, incentives and barriers have on the organization?
• Environmental – What environmental and ecological facets, both locally and farther afield, are likely to predetermine the business?
• Legal – What laws and legislation will exert influence on the style the business is carried out?

IFE, EFE, IE Matrices

The Internal Factor Evaluation matrix (IFE matrix) is a strategic management tool helping audit or evaluate major weaknesses and strengths in a business’s functional areas. In addition, IFE matrix serves as a basis for identifying and assessing relationships amongst those areas. The IFE matrix is utilised in strategy formulation.

The External Factor Evaluation matrix (EFE matrix) is a tool of strategic management that is typically utilised to assess current market conditions. It is an ideal instrument for visualising and prioritising the threats and opportunities a firm is facing.

The essential difference between the above mentioned matrices lies in the type of factors incorporated in the model; whilst the latter is engaged in internal factors, the former deals exceptionally with external factors – those exposed to social, political, economic, legal, etc. external forces.

Being a continuation of the EFE matrix and IFE matrix models, the Internal External matrix (IE matrix) rests upon an investigation of external and internal business factors integrated into one suggestive model.

Porter Five Forces Analysis

The Porter’s five forces analysis studies the industry of operation and helps the company find new sources of competitive advantage. The analysis surveys an industry through five major questions:

1. What composes a threat of substitute products and services?
2. Is there a threat of new competitors entering the market?
3. What is the intensity of competitive rivalry?
4. How big is the bargaining power of buyers?
5. How significant is the bargaining power of suppliers?

VRIO Analysis

VRIO stands for Value, Rarity, Imitability, Organization. This analysis helps to evaluate all company’s resources and capabilities and bring them together into one aggregate table that includes:

• Tangible resources
  • Financial
  • Physical
  • Technological
  • Organizational
• Intangible resources
  • Human
  • Innovation and Creativity
  • Reputation
• Organizational capabilities

The result of the analysis gives a clear picture of company’s competitive and economic implications, answering the questions if the resources mentioned above are:

• Valuable?
• Rare?
• Costly to imitate?
• Organized properly?